Kossiakoff Lab – Page 10 – University of Chicago

Nov 08 2001

High affinity RNase S-peptide variants obtained by phage display have a novel “hot-spot” of binding energy

Filed under publications

Dwyer JJ, Dwyer MA, Kossiakoff AA

Biochemistry 2001 Nov;40(45):13491-500

PMID: 11695896

Abstract

Using phage display mutagenesis, high affinity variants of RNase S-peptide were produced that bind to RNase S-protein over 100-fold more tightly than the wild type S-peptide. The S-peptide: S-protein interface was further characterized using “biased” phage display libraries, where each targeted residue was …

Apr 08 2000

Biosynthetic phage display: a novel protein engineering tool combining chemical and genetic diversity

Filed under publications

Dwyer MA, Lu W, Dwyer JJ, Kossiakoff AA

Chem. Biol. 2000 Apr;7(4):263-74

PMID: 10780926

Abstract

BACKGROUND: Molecular diversity in nature is developed through a combination of genetic and chemical elements. We have developed a method that permits selective manipulation of both these elements in one protein engineering tool. It combines the ability to introduce non-natural …

Recent News

Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies
March 1, 2021
The Recombinant Antibody Network (RAN), a consortium comprising research groups from UC San Francisco (UCSF), the University of Chicago, and the University of Toronto have expanded a previous research collaboration with Bristol Myers Squibb, aimed to create and develop high-performance recombinant antibodies against diverse targets in human cells. The RAN was founded in 2012 by … Continue reading
Anthony Kossiakoff, University of Chicago 2019 Christian B. Anfinsen Award Winner
January 2, 2020
The Christian B. Anfinsen Award- Sponsored by The Protein Society, recognizes technological achievement or significant methodological advances in the field of protein science. The recipient of this award in 2019 is Professor Anthony Kossiakoff (University of Chicago). Professor Kossiakoff’s achievements have had broad and sustained impact through the development of innovative technologies and major discoveries … Continue reading
Absolute Antibody Partners with the Recombinant Antibody Network to Facilitate Access to Engineered Recombinant Antibodies
December 11, 2019
Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, has announced a partnership with the Recombinant Antibody Network (RAN), a consortium of three expert centers at the University of Chicago, University of Toronto, and UC San Francisco (UCSF) with a common goal to generate recombinant antibodies at a proteome-wide scale.
Automated antibody phage display selection and screening system
January 29, 2018
Advanced robotic system designed to screen thousands of recombinant antibodies without human intervention.

Engineered ultra-high affinity synthetic antibodies for SARS-CoV-2 neutralization and detection

Recognition of an α-helical hairpin in P22 large terminase by a synthetic antibody fragment

Structure of human Frizzled5 by fiducial-assisted cryo-EM supports a heterodimeric mechanism of canonical Wnt signaling

Synthetic antibodies against BRIL as universal fiducial marks for single-particle cryoEM structure determination of membrane proteins

Structure and mechanism of the ER-based glucosyltransferase ALG6

High affinity RNase S-peptide variants obtained by phage display have a novel “hot-spot” of binding energy

Biosynthetic phage display: a novel protein engineering tool combining chemical and genetic diversity

Main Menu

Automated antibody phage display selection and screening system

Recent News

Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies

Anthony Kossiakoff, University of Chicago 2019 Christian B. Anfinsen Award Winner

Absolute Antibody Partners with the Recombinant Antibody Network to Facilitate Access to Engineered Recombinant Antibodies

Automated antibody phage display selection and screening system